Fernando Bermejo
About
In The Last Decade
Fernando Bermejo
130 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 111
- Genetics 1.3k
- Surgery 1.3k
- Epidemiology 1.0k
- Gastroenterology 401
- Immunology 387
Countries citing papers authored by Fernando Bermejo
This map shows the geographic impact of Fernando Bermejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Bermejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Bermejo more than expected).
Fields of papers citing papers by Fernando Bermejo
This network shows the impact of papers produced by Fernando Bermejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Bermejo. The network helps show where Fernando Bermejo may publish in the future.
Co-authorship network of co-authors of Fernando Bermejo
This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Bermejo. A scholar is included among the top collaborators of Fernando Bermejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Bermejo. Fernando Bermejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 14 | |
| 4 | 13 | |
| 5 | 21 | |
| 6 | Fármacos biológicos en la enfermedad inflamatoria intestinal: indicación y cuidados | 1 |
| 7 | [Biosimilars in inflamatory bowel disease: Management and care]. | 2 |
| 8 | [Biological drugs in inflammatory bowel disease: Management and care]. | 1 |
| 9 | 26 | |
| 10 | 18 | |
| 11 | 19 | |
| 12 | Second-Line Rescue Therapy with Levofloxacin After Failure of Treatment to Eradicate Helicobacter Pylori Infection: Time Trends in a Spanish Multicenter Study of 1300 Patients | 0 |
| 13 | 53 | |
| 14 | 29 | |
| 15 | 24 | |
| 16 | 74 | |
| 17 | 110 | |
| 18 | 20 | |
| 19 | Collagenous colitis in Spain: a report of nine new cases. | 5 |
| 20 | [The usefulness of the detection of Cys282Tyr and His63Asp mutations in the diagnosis of hereditary hemochromatosis]. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.